market folly

Crispin Odey's UK firm Odey Asset Management has disclosed a new position in London listed Epistem Holdings (LON:  EHP). Due to trading on the 12th of April, Odey hold 5.02% of Epistem's voting rights. It appears that the Odey UK Absolutue Return Fund, managed by James Hanbury, is the main holder of the position with 4.2% of voting rights. 

Per Google Finance - "Epistem Holdings Plc is a holding company. The Company is engaged in  provision of services to the biotechnology and pharmaceutical industries, covering pre-clinical  testing and gene biomarker and diagnostic services and the development of novel therapeutics for  partner companies. The trading activity of the Company is principally undertaken in the subsidiary  undertaking, Epistem Limited. The Company operates in three segments: Contract Research  Services, Personalized Medicine and Novel Therapies. Contract Research Services provides pre-  clinical testing services. Personalized Medicine specializes in molecular measures of biological effect  and point of care molecular diagnostic testing. Novel Therapies is discovering key regulators of  epithelial stem cells."

You can read about other recent portfolio activity from Odey here.